burkholderia pseudomallei | lactobacillus acidophilus | bifidobacterium bifidum | helicobacter pylori kx2 mgep | aeromonas cavia | GeneSet Name |
-0.00050 | -0.00055 | -0.00023 | -0.01305 | -0.00479 | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP |
-0.00532 | -0.00129 | -0.00072 | -0.06916 | -0.00040 | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP |
-0.00016 | -0.00187 | -0.00139 | -0.04124 | -0.00026 | BORCZUK_MALIGNANT_MESOTHELIOMA_UP |
-0.11862 | -0.00124 | -0.00385 | -0.08620 | -0.03487 | NCI_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL |
-0.00078 | -0.00041 | -0.00004 | -0.10206 | -0.00015 | KEGG_CITRATE_CYCLE_TCA_CYCLE |
-0.10712 | -0.17298 | -0.14029 | -0.08425 | -0.06246 | SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC |
-0.00534 | -0.00308 | -0.00153 | -0.12859 | -0.01206 | GRADE_COLON_CANCER_UP |
-0.00001 | -0.00617 | -0.01617 | -0.00628 | -0.00014 | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 |
-0.12577 | -0.00110 | -0.00423 | -0.01868 | -0.00014 | STEIN_ESRRA_TARGETS |
-0.00001 | -0.00436 | -0.00031 | -0.14035 | -0.18691 | IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR |
-0.00001 | -0.06903 | -0.01713 | -0.01552 | -0.00031 | KEGG_PARKINSONS_DISEASE |
-0.02533 | -0.00201 | -0.02951 | -0.15550 | -0.05430 | SANA_RESPONSE_TO_IFNG_DN |
-0.00117 | -0.01395 | -0.00190 | -0.06081 | -0.00401 | CAFFAREL_RESPONSE_TO_THC_DN |
-0.00796 | -0.03486 | -0.00740 | -0.08702 | -0.00074 | KEGG_HUNTINGTONS_DISEASE |
-0.03491 | -0.07899 | -0.00390 | -0.01359 | -0.01918 | CORUM_F1F0-ATP_SYNTHASE_EC_3.6.3.14_MITOCHONDRIAL |
-0.00177 | -0.05131 | -0.01923 | -0.12405 | -0.06042 | LOPEZ_MBD_TARGETS |
-0.00069 | -0.00627 | -0.00053 | -0.06341 | -0.00011 | LEE_LIVER_CANCER_SURVIVAL_DN |
-0.12766 | -0.02277 | -0.09374 | -0.07154 | -0.01907 | KEGG_PROPANOATE_METABOLISM |
-0.04260 | -0.04967 | -0.07164 | -0.00913 | -0.00050 | REACTOME_DIABETES_PATHWAYS |
-0.02945 | -0.02032 | -0.06198 | -0.08492 | -0.12680 | DAIRKEE_TERT_TARGETS_UP |
-0.00046 | -0.09173 | -0.07638 | -0.18262 | -0.09508 | TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP |
-0.01642 | -0.06171 | -0.02139 | -0.08659 | -0.17884 | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP |
-0.00246 | -0.03992 | -0.02064 | -0.00090 | -0.17432 | CHEN_HOXA5_TARGETS_9HR_DN |
-0.00728 | -0.01819 | -0.01366 | -0.03508 | -0.00008 | REACTOME_REGULATION_OF_INSULIN_SECRETION |
-0.12827 | -0.00604 | -0.06933 | -0.00656 | -0.00074 | REACTOME_CHOLESTEROL_BIOSYNTHESIS |
-0.05144 | -0.08618 | -0.00556 | -0.00605 | -0.02113 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING |
-0.00040 | -0.00066 | -0.00182 | -0.08936 | -0.00134 | UDAYAKUMAR_MED1_TARGETS_UP |
-0.03319 | -0.00030 | -0.00823 | -0.03129 | -0.03014 | PENG_LEUCINE_DEPRIVATION_DN |
-0.10305 | -0.06189 | -0.12411 | -0.08393 | -0.00317 | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN |
-0.00299 | -0.00080 | -0.00001 | -0.07933 | -0.06050 | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN |
-0.02186 | -0.12246 | -0.13191 | -0.08874 | -0.12028 | BIOCARTA_AKAP95_PATHWAY |
-0.13553 | -0.04825 | -0.03076 | -0.02846 | -0.17645 | NUYTTEN_NIPP1_TARGETS_DN |
-0.03184 | -0.05717 | -0.15117 | -0.09820 | -0.19744 | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
-0.04011 | -0.01350 | -0.00481 | -0.11512 | -0.00501 | SESTO_RESPONSE_TO_UV_C6 |
-0.00050 | -0.00029 | -0.00144 | -0.16100 | -0.00189 | PENG_GLUTAMINE_DEPRIVATION_DN |
-0.05126 | -0.08124 | -0.00693 | -0.00769 | -0.02106 | NCI_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING |
-0.12333 | -0.08770 | -0.15048 | -0.15875 | -0.18977 | CORUM_OLIGOSACCHARYLTRANSFERASE_COMPLEX_STT3B_VARIANT |
-0.13439 | -0.00068 | -0.00352 | -0.08274 | -0.03465 | REACTOME_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL |
-0.18074 | -0.14415 | -0.15911 | -0.05512 | -0.16729 | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL |
-0.13747 | -0.11043 | -0.09986 | -0.09261 | -0.06720 | KORKOLA_YOLK_SAC_TUMOR_UP |
-0.10807 | -0.03007 | -0.02512 | -0.03318 | -0.08267 | REACTOME_INFLUENZA_LIFE_CYCLE |